Yuki Satoshi

• 2019 - 2022 Effect of amnion-derived mesenchymal stem cells for the treatment of radiation-induced oral mucositis

• Satoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, Hiroya Taniguchi, Hideaki Bando, Manabu Shiozawa, Tomohiro Nishina, Hisateru Yasui, Akiyoshi Kanazawa, Koji Ando, et al. Plasma Angiogenic Factors as Predictors of the Efficacy of Second-line Chemotherapy Combined with Angiogenesis Inhibitors in Metastatic Colorectal Cancer: Results From the GI-SCREEN CRC-Ukit Study. Clinical colorectal cancer. 2024
• 原田 一顕, 中村 赳晶, 渡辺 亮介, 山村 貴洋, 結城 敏志, 坂本 直哉, 川本 泰之, 小松 嘉人, 打浪 雄介, 田口 大志, et al. 胸部食道がん化学放射線療法における重症放射線食道炎に関する後方視的研究. 北海道医学雑誌. 2023. 98. 2. 139-140
• Takeshi Kajiwara, Tomohiro Nishina, Riu Yamashita, Yoshiaki Nakamura, Manabu Shiozawa, Satoshi Yuki, Hiroya Taniguchi, Hiroki Hara, Takashi Ohta, Taito Esaki, et al. Sidedness-Dependent Prognostic Impact of Gene Alterations in Metastatic Colorectal Cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN). Cancers. 2023. 15. 21
• 胡 慶江, 原田 一顕, 川上 武志, 緒方 貴次, 伏木 邦博, 谷口 浩也, 室 圭, 安藤 幸滋, 南原 翔, 川本 泰之, et al. 転移性大腸癌におけるレゴラフェニブの開始用量が治療成績に対する影響. 日本癌治療学会学術集会抄録集. 2023. 61回. O15-5
• Satoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, Hiroya Taniguchi, Hideaki Bando, Manabu Shiozawa, Tomohiro Nishina, Hisateru Yasui, Yoshinori Kagawa, Naoki Takahashi, et al. Role of plasma angiogenesis factors in the efficacy of first-line chemotherapy combined with biologics in RAS wild-type metastatic colorectal cancer: Results from the GI-SCREEN CRC-Ukit study. Cancer medicine. 2023

ｍore...

• Kentaro Yamazaki, Satoshi Yuki, Hiroya Taniguchi, Hideaki Bando, Yu Sunakawa, Manabu Shiozawa, Hisateru Yasui, Naoki Takahashi, Hironaga Satake, Nobuhisa Matsuhashi, et al. Impact of plasma VEGF-A, VEGF-D and PlGF on the efficacy of 2nd-line chemotherapy combined with biologics in mCRC. ANNALS OF ONCOLOGY. 2022. 33. S479-S479
• Yoshinori Kagawa, Daisuke Kotani, Hideaki Bando, Naoki Takahashi, Tetsuya Hamaguchi, Akiyoshi Kanazawa, Takeshi Kato, Koji Ando, Hironaga Satake, Eiji Shinozaki, et al. Plasma RAS dynamics and anti-EGFR rechallenge efficacy in patients with RAS/BRAF wild-type metastatic colorectal cancer: REMARRY and PURSUIT trials. JOURNAL OF CLINICAL ONCOLOGY. 2022. 40. 16
• Satoshi Yuki, Yu Sunakawa, Kentaro Yamazaki, Hiromichi Shirasu, Hiroya Taniguchi, Toshiki Masuishi, Manabu Shiozawa, Hideaki Bando, Tomohiro Nishina, Hisateru Yasui, et al. Analysis of plasma angiogenesis factors on the efficacy of first-line (1L) chemotherapy (chemo) combined with biologics in RAS wild-type metastatic colorectal cancer (mCRC): Results from GI-SCREEN CRC Ukit study. JOURNAL OF CLINICAL ONCOLOGY. 2022. 40. 16
• 塚田 祐一郎, 坂東 英明, 稲守 宏冶, 冨樫 庸介, 結城 敏志, 小松 嘉人, 本間 重紀, 武冨 紹信, 植村 守, 加藤 健志, et al. 大腸癌周術期治療の臨床開発と将来展望 進行直腸癌に対する化学放射線療法と免疫チェックポイント阻害剤を用いた術前治療. 日本癌治療学会学術集会抄録集. 2021. 59回. SY2-4
• Koji Inamori, Yosuke Togashi, Hideaki Bando, Yuichiro Tsukada, Shota Fukuoka, Ayako Suzuki, Yutaka Suzuki, Daisuke Kotani, Motohiro Kojima, Makoto Fukui, et al. Efficacy predictors of preoperative CRT and consolidation nivolumab in patients with locally advanced rectal cancer. ANNALS OF ONCOLOGY. 2021. 32. S343-S343

ｍore...

• NORTH/HGCSG1003 Stage III結腸癌に対する術後補助化学療法FOLFOXの第II相研究 腫瘍内科医と外科医の比較
  (日本大腸肛門病学会雑誌 2019)
• XELOX+bevacizumab療法が奏効しR0切除が得られたAFP産生大腸癌同時性肝転移の1例
  (日本外科系連合学会誌 2018)
• Imatinib不応・不耐GISTに対するsunitinibの有効性について 遺伝子変異別の検討
  (日本癌治療学会学術集会抄録集 2017)
• HER2陽性胃癌に対するトラスツズマブ/イリノテカン併用療法の第II相試験(HGCSG1201)
  (日本癌治療学会学術集会抄録集 2017)
• 前治療における腫瘍増殖速度がレゴラフェニブとTAS-102の抗腫瘍効果に与える影響
  (日本癌治療学会学術集会抄録集 2017)

ｍore...

• 医学博士 (北海道大学)

The Japan Gastroenterological Endoscopy Society ,  The Japanese Society of Gastroenterology ,  Japanese Association for Cancer Prevention ,  Japanese Association of Supportive Care in Cancer ,  The Japanese Society for Familial Tumors ,  Japanese Gastric Cancer Association ,  Japan Society of Clinical Oncology ,  The Japanese Society of Internal Medicine ,  European Society of Medical Oncology ,  American Society of Clinical Oncology ,  Japanese Society of Medical Oncology